Crossmark

Validation of the HPLC–PDA method for detection of eluxadoline and rifaximin in rat plasma and application in a pharmacokinetic study

Published Online: 2022-01-25

Published Print: 2022-12

Authors

Karla, Vijendar Reddy

Palakeeti, Babji

Raghasudha, M.

Chitta, Raghu http://orcid.org/0000-0003-1383-1164
Funding

Funding for this research was provided by:

Science and Engineering Research Board (DST, CRG/2018/002661, SR/FST/CSII/2018/65)

National Institute of Technology Warangal (P1078 Plan Gen.-RSM, P1082 Plan Gen.-RSM)
License Information

Text and Data Mining valid from 2022-01-25

Version of Record valid from 2022-01-25
More Information

Article History

Received: 21 August 2021

Accepted: 13 January 2022

First Online: 25 January 2022

Declarations

:

: Animal house facility were provided by Manisha Laboratories, Mumbai, Maharashtra, India. Animal experiments and study protocols are approved by the Institutional Animal Ethics Committee with reference number (Registration No.: 1074/PO/Re/S/05/CPCSEA), under CPCSEA, Delhi, India. All institutional and national guidelines for the care and use of laboratory animals were followed.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current